CMS proposes in 428.202(e)(4) that for a subsequently approved drug for which there are no quarters during the first calendar year beginning after the drug's first marketed date for which AMP has been reported to the MDRP, the benchmark period CPI-U is the CPI-U for January of the calendar year in which such drug has at least 1 quarter of AMP reported
Nicotine replacement therapy (NRT) involves using products containing low doses of nicotine like gum and skin patches to cut down on cravings and lessen withdrawal symptoms after you quit smoking
This feedback from interested parties included: The patient cohort for the measure should be expanded, while still accounting for patient heterogeneity to increase clinician coverage and capture more clinically-related services
Reduces the risk of heart disease, respiratory issues, cancers, and other smoking-related illnesses
Alcohol-induced sexual dysfunction (F10.981) includes difficulties with desire, arousal, or performance directly attributable to alcohol use
